إعلان
إعلان
TRAW
Traws Pharma, Inc. Common Stock
1.34
USDبرعاية
-0.06
-4.61%
٠٩ يناير, ١٥:٥٨ UTC -5
مغلق
بعد الإغلاق
1.35
+0.01
+0.67%
تقارير أرباح TRAW
النسبة الإيجابية المفاجئة
TRAW تفوق 24 من 34 آخر التقديرات.
71%
التقرير التالي
بيانات التقرير القادم
٣٠ مارس ٢٠٢٦
Estimate for Q4 25 (Revenue/ EPS)
--
/-$1.94
التغير الضمني من Q3 25 (Revenue/ EPS)
--
/--
التغير الضمني من Q4 24 (Revenue/ EPS)
-100.00%
/-102.03%
Traws Pharma, Inc. Common Stock earnings per share and revenue
On ١٣ نوفمبر ٢٠٢٥, TRAW reported earnings of -- USD per share (EPS) for Q3 25, -- the estimate of -9.34 USD, resulting in a --% surprise. Revenue reached --, compared to an expected 61.20 ألف, with a --% difference.
Looking ahead to Q4 25, 3 المحللين forecast an EPS of -1.94 USD, with revenue projected to reach -- USD, implying an -- of --% EPS, and -- of --% in Revenue from the last quarter.
الأسئلة الشائعة
What were Traws Pharma, Inc. Common Stock's earnings and revenue for the latest quarter Q3 2025?
For Q3 2025, Traws Pharma, Inc. Common Stock reported EPS of --, missing estimates by --, and revenue of --, -- -- expectations.
How did the market react to Traws Pharma, Inc. Common Stock's Q3 2025 earnings?
The stock price moved -- --, changed from -- before the earnings release to -- the day after.
When is Traws Pharma, Inc. Common Stock expected to report next?
The next earning report is scheduled for ٣٠ مارس ٢٠٢٦.
What are the forecasts for Traws Pharma, Inc. Common Stock's next earnings report?
Based on 3
المحللين, Traws Pharma, Inc. Common Stock is expected to report EPS of -$1.94 and revenue of -- for Q4 2025.
Which companies are reporting earnings today?
شيك FXEmpire's Earnings Calendar for today's list of reporting companies.
إعلان